NHS National Proprietary Pharmaceuticals - Natalizumab Injection
key details
| Value | £55,000,000 |
|---|---|
| Status | planned |
| Category (CPV) | 33600000 |
| Contract start | 1 Jan 2024 |
| Contract end | 31 Dec 2025 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-de023117-dc64-4479-9ce0-142f23b83eaf |
description
CM/PHR/23/5701 NHS National Proprietary Pharmaceuticals - Natalizumab Injection
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 15 Aug 2023 | Planning (planning) | · | 062282d9-4efb-4f98-a234-6fc752fdd3e3-671922 |
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.